Quantcast

Latest Alexza Pharmaceuticals Inc. Stories

2014-07-17 16:26:43

MOUNTAIN VIEW, Calif., July 17, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended June 30, 2014 on Thursday, August 7, 2014, following the close of the U.S. financial markets. The Company will also host an investor conference call and live webcast on the same day at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to provide a company update and discuss the financial results....

2014-06-30 16:26:55

MOUNTAIN VIEW, Calif., June 30, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the promotion of Edwin S. Kamemoto, Ph.D., to the newly created position of Senior Vice President, Regulatory Affairs. Dr. Kamemoto will have primary responsibility for leading and directing all regulatory affairs and global pharmacovigilence activities. Dr. Kamemoto has been Alexza's Vice President, Regulatory Affairs since July 2012. He joined Alexza in 2006 as...

2014-05-05 16:27:31

Management to Review Results and Provide Business Update in Conference Call Scheduled Today for 5:00 p.m. Eastern Time MOUNTAIN VIEW, Calif., May 5, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended March 31, 2014. The net loss for the first quarter was $10.7 million compared to $20.7 million during the same quarter in 2013. At March 31, 2014, Alexza had consolidated cash, cash equivalents, marketable securities and...

2014-04-30 16:30:47

MOUNTAIN VIEW, Calif., April 30, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in the Nordic countries (Sweden, Norway, Denmark and Finland). Grupo Ferrer Internacional, S.A. ("Ferrer") is commercializing ADASUVE in the Nordic countries through a distribution agreement with Medivir AB. Ferrer is Alexza's commercial partner for ADASUVE in the Europe, Latin America and the...

2014-04-17 08:28:57

MOUNTAIN VIEW, Calif., April 17, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Winston R. Brown, Jr. has joined the Company as Vice President, Quality. Mr. Brown brings more than two decades of experience in global quality, regulatory compliance and development operations working with diverse biopharmaceuticals, medical devices and nutritionals in globally integrated companies. In this position, Mr. Brown has primary responsibility for Quality...

2014-04-16 16:30:48

MOUNTAIN VIEW, Calif., April 16, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2014 on Monday, May 5, 2014, following the close of the U.S. financial markets. The Company will also host an investor conference call and live webcast on the same day at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to provide a company update and discuss the financial results....

2014-03-19 08:30:28

Notes Secured by Royalties and Milestones on U.S. Sales of ADASUVE® MOUNTAIN VIEW, Calif., March 19, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) (Alexza) announced today that it has closed a private placement to institutional investors of $45.0 million of non-recourse notes (the "Notes"). The Notes are secured by royalties and potential milestones from U.S. sales of ADASUVE(®) (loxapine) inhalation powder. Alexza's commercial partner for ADASUVE in the U.S....

2014-03-13 08:29:52

MOUNTAIN VIEW, Calif. and BARCELONA, Spain, March 13, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Ferrer today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Romania. Ferrer is Alexza's commercial partner for ADASUVE in the European Union (EU), Latin America and the Commonwealth of Independent States countries. Ferrer is commercializing the product in Romania through a distribution agreement with Galenica, S.A....

2014-03-06 16:27:30

Management to Review Results and Provide Business Update in Conference Call Scheduled Today for 5:00 p.m. Eastern Time MOUNTAIN VIEW, Calif., March 6, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter and year ended December 31, 2013. The net loss for the fourth quarter was $5.7 million compared to $10.3 million during the same quarter in 2012. The net loss for the years ended December 31, 2013 and 2012 was $39.6 million and...

2014-03-03 08:31:55

ADASUVE is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults MOUNTAIN VIEW, Calif., March 3, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the U.S. commercial launch of ADASUVE(®) (loxapine) inhalation powder 10mg by its commercial partner, Teva Pharmaceutical Industries Ltd., (NYSE: TEVA). ADASUVE is the first and only orally inhaled medicine for the acute...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related